Fundraising Fox
Neurolase
2 known investors
Find your way into Neurolase
Sign up to see every warm intro you have to Neurolase
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neurolase team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Neurolase develops AI-powered technology for brain surgery, aiming to improve surgical precision and patient outcomes in neurosurgery, particularly for brain tumor resection. The company is built by a team of clinicians, scientists and engineers to set a new intraoperative standard for neurosurgeons.
Founders & leadership
MK
Monika KottCo-Founder & CEOShe has background in commercial advisory and investment focused on AI applications in healthcare, medtech, and biotech.
BV
Babar VaqasCo-Founder & CMOBabar Vaqas is a neurosurgeon trained at Oxford University, Cambridge, and London who holds a PhD from Imperial College London focused on brain tumor surgery. He specializes in neuro-oncology and minimally invasive surgical techniques, with experience in clinical trial design for emerging medical technologies.
Investors · 2
Frequently asked questions
- What does Neurolase do?
- Neurolase develops AI-powered technology for brain surgery, aiming to improve surgical precision and patient outcomes in neurosurgery, particularly for brain tumor resection. The company is built by a team of clinicians, scientists and engineers to set a new intraoperative standard for neurosurgeons.
- Who founded Neurolase?
- Neurolase was founded by Monika Kott, Babar Vaqas.
- Who are Neurolase's investors?
- Neurolase's investors include Oxford Technology Management, Zinc.